COMPARATIVE EVALUATION OF THE PROTECTIVE EFFICACY OF DIFFERENT VACCINATION PROGRAMS AGAINST A VIRULENT FIELD STRAIN OF THE NEWCASTLE DISEASE VIRUS IN BROILERS

Sarcheshmei, M; Dadras, H; Mosleh, N; Mehrabanpour, MJ

doi:10.1590/1806-9061-2015-0128

Despite the intensive vaccination programs used for controlling Newcastle disease (ND) in the Iranian poultry industry, outbreaks of ND have been reported in poultry farms. This study was conducted to evaluate the effectiveness of vaccines for the protection against ND infection and virus-shedding period of velogenic Newcastle disease virus (vNDV) field strain after different immunization schemes. Eight groups of commercial broiler chickens were used. Six groups were vaccinated with different vaccination programs using commercial live and inactivated ND vaccines. All groups, except for group 8, were challenged with a virulent field isolate (10⁴EID50/bird) at 28 days of age. Clinical signs, mortality rate and gross lesions were investigated. Antibody titers were assayed by hemagglutination inhibition test and fecal virus shedding was determined for 14 days post challenge (dpc) with 3-day intervals by the RT-PCR method. All unvaccinated-challenged control birds died. Vaccination with these ND vaccines protected chickens from clinical disease. The mortality rate in the vaccinated groups was significantly lower than in the positive control group. However, vaccinated chickens shed the challenge virus in fecal samples. Although the different vaccination regimens displayed close degrees of protection against the disease, the best protection was observed in broilers primed with the live B1 vaccine via eye drop simultaneously with inactivated vaccine at 8 days of age and boosted with B1 or LaSota via drinking water on day 18. In conclusion, the currently used vaccines with different vaccination schemes can protect chickens against the disease in areas where ND is endemic, while the spread of the field virus to other flocks cannot be prevented.

Keywords:
Broiler chickens; Newcastle disease virus; Vaccination program; Virus shedding period

[TFN1] ^a
^bc Different superscript letters denote significantly differences (p ≤ 0.05) in each column.

[TFN2] *only one bird was alive on day 10 pc in this group.

Primer	Sequence
A (R)	5 ´ -TTGATGGCAGGCCTCTTGC-3 ´
B (F)	5 ´ -AGCGTCT-CTGTCTCCT-3 ´
C (F)	5 ´ -G(A/G)CG(A/T)-CCCTGT(C/T)TCCC-3 ´

Days Groups	1	8	15	22	28 (0 pc)	33 (5 pc)	38 (10 pc)	42 (14 pc)
1	6.9±0.95^a	5.2±0.37^a	4.7±0.25^a	5.4±0.4^a	5.2±0.2^a	6.4±0.24^a	5.4±0.24^ab	5.4±0.97^a
2	6.9±0.95^a	5.4±0.4^a	4±0.31^a	5±0.31^a	5.4±0.4^a	6^a	7.8±0.73^a	8.2±0.48^b
3	6.9±0.95^a	6.8±0.2^b	4.6±0.67^a	4.2±0.58^a	5.2±0.37^a	4.8±0.2^b	7.8±0.96^a	10^b
4	6.9±0.95^a	6.6±0.24^b	5.2±0.2^a	4±0.63^a	5.8±0.48^a	4.6±0.24^b	8.4±0.87^a	9.4±0.4^b
5	6.9±0.95^a	5.2±0.25^a	5±0.31^a	5±0.31^a	5.2±0.2^a	4.8±0.37^b	6.2±1.06^a	9.2±0.48^b
6	6.9±0.95^a	5.2±0.25^a	5.2±0.37^a	4.8±0.66^a	6.8±0.37^a	4.4±0.24^b	8.4±0.4^a	9.2±0.37^b
7	6.9±0.95^a	5.2±0.25^a	4.6±0.24^a	3.7±0.25^a	2.8±0.2^b	3^c	3^*b	-
8	6.9±0.95^a	5±0.4^a	4.4±0.24 ^a	3.6±0.24^a	2.4±0.24^b	2.2±0.2^c	2.4^b	2.6±0.24^c

Groups	Days post challenge
Groups	3	6	9	14
1	1/5^ab	2/5^a	0/5^a	0/5^a
2	3/5^ab	3/5^a	1/5^a	1/5^a
3	1/5^ab	3/5^a	0/5^a	1/5^a
4	4 /5^a	2/5^a	0/5^a	1/5^a
5	3/5^ab	3/5^a	0/5^a	1/5^a
6	4/5^a	2/5^a	3/5^a	1/5^a
7	2/5^ab	3/5^a	2/2^a	NS
8	0/5^b	0/5^a	0/5^a	0/5^a